Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...